You have been logged out of VisualDx or your session has expired.

Please reload this page and sign into VisualDx to continue.

  VisualDx Mobile   Select Language

Get VisualDx Mobile

There are VisualDx mobile apps available for iOS and Android devices.

You will need a VisualDx account to use the mobile apps.

Already have an account? Sign In or
sign up for a free trial.

Users with VisualDx accounts earn CME credits for using VisualDx.

Already have an account? Sign In or
sign up for a free trial.

Create a Personal Account

E-mail (username)
Verify Password
First Name
Last Name

Personal Account Created

Mobile Access

You can now download VisualDx for your iOS and Android devices. Launch the VisualDx app from your device and sign in using your VisualDx personal account username and password.

CME Certification

Sign in with your personal account to earn and claim CME credits through VisualDx. Credits can be earned by building a differential or looking up a diagnosis.

Version: 7.13.1441   (build df7aed4)
Select Language

Select Region

Send us your feedback

This field is required

Oops! There was an issue during submission. Please try again. If the problem persists, email with your feedback.

Thank You!

We appreciate your feedback and you will be hearing from us soon.


Share This Page

Thank You!

We have sent an e-mail with a link to the current page.


E-mail This Patient Information Sheet

Thank You!

We have sent an e-mail with this patient information.


Image Contributors


  • Christine Ahn MD
    Carl Allen DDS, MSD
    Brandon Ayres MD
    Howard P. Baden MD
    Robert Baran MD
    Keira Barr MD
    Gregory J. Basura MD, Ph.D
    Donald Belsito MD
    Jeffrey D. Bernhard MD
    Jesse Berry MD
    Victor Blanco MD
    Benjamin R. Bohaty MD
    William Bonnez MD
    Sarah Brenner MD
    Robert A. Briggaman MD
    Robert Brodell MD
    Roman Bronfenbrener MD
    Walter Brooks MD
    William Buckley MD
    Philip Bulterys MD, PhD (candidate)
    Susan Burgin MD
    Sonya Burton MD
    Sean P. Bush MD, FACEP
    Jeffrey Callen MD
    Scott Camazine MD
    Michael Cardwell
    Shelley D. Cathcart MD
    Robert Chalmers MD, MRCP, FRCP
    Chia-Yu Chu MD, PhD
    Flavio Ciferri MD
    Maria Rosa Cordisco MD
    Noah Craft MD, PhD
    John T. Crissey MD
    Harold E. Cross MD, PhD
    Charles E. Crutchfield III MD
    Adriana Cruz MD
    Donna Culton MD, PhD
    Bart J. Currie MBBS, FRACP, DTM&H
    Chicky Dadlani MD
    Alexander Dane DO
    C. Ralph Daniel III MD
    Thomas Darling MD, PhD
    William Delaney MD
    Damian P. DiCostanzo MD
    Ncoza Dlova MD
    James Earls MD
    Libby Edwards MD
    Melissa K. Egge MD
    Charles N. Ellis MD
    Rachel Ellis MD
    David Elpern MD
    Nancy Esterly MD
    Stephen Estes MD
    E. Dale Everett MD
    Janet Fairley MD
    David Feingold MD
    Jennifer J. Findeis-Hosey MD
    Benjamin Fisher MD
    Henry Foong MBBS, FRCP
    David Foster MD, MPH
    Brian D. Foy PhD
    Michael Franzblau MD
    Vincent Fulginiti MD
    Sunir J. Garg MD, FACS
    Kevin J. Geary MD
    Lowell Goldsmith MD, MPH
    Sethuraman Gomathy MD
    Bernardo Gontijo MD, PhD
    Kenneth Greer MD
    Kenneth G. Gross MD
    Alan Gruber MD
    Nathan D. Gundacker MD
    Akshya Gupta MD
    Vidal Haddad MSC, PhD, MD
    Edward Halperin MD, MA
    Ronald Hansen MD
    John Harvey
    Rizwan Hassan MD
    Michael Hawke MD
    Jason E. Hawkes MD
    Peter W. Heald MD
    David G. Hicks MD
    Sarah Hocker DO
    Ryan J. Hoefen MD, PhD
    Li-Yang Hsu MD
    William Huang MD
    Sanjana Iyengar MD
    Alvin H. Jacobs MD
    Saagar Jadeja MD
    Shahbaz A. Janjua MD
    Joshua J. Jarvis MD
    Kit Johnson
    Zachary John Jones MD
    Robert Kalb MD
    A. Paul Kelly MD
    Henry Kempe MD
    Loren Ketai MD
    Sidney Klaus MD
    Ashwin Kosambia MD
    Jessica A. Kozel MD
    Carl Krucke
    Mario E. Lacouture MD
    Joseph Lam MD
    Alfred T. Lane MD
    Edith Lederman MD
    Nahyoung Grace Lee MD
    Pedro Legua MD, PhD
    Robert Levin MD
    Bethany Lewis MD
    Sue Lewis-Jones FRCP, FRCPCH
    Taisheng Li MD
    Christine Liang MD
    Shari Lipner MD, PhD
    Adam Lipworth MD
    Jason Maguire MD
    Mark Malek MD, MPH
    Jere Mammino DO
    Ricardo Mandojana MD
    Lynne Margesson MD
    Thomas J. Marrie MD
    Maydel Martinez MD
    Ralph Massey MD
    Patrick McCleskey MD
    Karen McKoy MD
    Thomas McMeekin MD
    Josette McMichael MD
    Somchai Meesiri MD
    Joseph F. Merola MD
    Mary Gail Mercurio MD
    Anis Miladi MD
    Larry E. Millikan MD
    Dan Milner Jr. MD
    Zaw Min MD
    Stephanie Montero
    Alastair Moore MD
    Keith Morley MD
    Dean Morrell MD
    Samuel Moschella MD
    Rehan Naseemuddin MD
    Taimor Nawaz MD
    Vic Newcomer MD
    John Nguyen MD
    Matilda Nicholas MD
    Thomas P. Nigra MD
    Steven Oberlender MD, PhD
    Maria Teresa Ochoa MD
    Art Papier MD
    Lawrence Parish MD
    Tanner Parrent MD
    Mukesh Patel MD
    Lauren Patty-Daskivich MD
    David Peng MD, MPH
    Robert Penne MD
    Nitipong Permpalung MD
    Miriam Pomeranz MD
    Doug Powell MD
    Harold S. Rabinovitz MD
    Christopher J. Rapuano MD
    Sireesha Reddy MD
    Angela Restrepo MD, PhD
    Bertrand Richert MD, PhD
    J. Martin Rodriguez, MD, FACP
    Theodore Rosen MD
    Misha Rosenbach MD
    Scott Schiffman MD
    Robert H. Schosser MD
    Glynis A. Scott MD
    Carlos Seas MD, MSc
    Deniz Seçkin MD
    Daniel Sexton MD
    Paul K. Shitabata MD
    Tor Shwayder MD, FAAP, FAAD
    Elaine Siegfried MD
    Gene Sienkiewicz MD
    Christye Sisson
    Philip I. Song MD
    Mary J. Spencer MD, FAAP
    Lawrence B. Stack MD
    Sarah Stein MD
    William Van Stoecker MD
    Frances J. Storrs MD
    Erik J. Stratman MD
    Lindsay C. Strowd MD
    Erika Summers MD
    Belinda Tan MD, PhD
    Robert Tomsick MD
    Hensin Tsao MD, PhD
    Richard P. Usatine MD
    Jenny Valverde MD
    Vishalakshi Viswanath MD
    Susan Voci MD
    Lisa Wallin ANP, FCCWS
    Douglas Walsh MD
    Ryan R. Walsh MD
    George Watt MD
    Clayton E. Wheeler MD
    Sally-Ann Whelan MS, NP, CWOCN
    Jan Willems MD, PhD
    James Henry Willig MD, MPH
    Karen Wiss MD
    Vivian Wong MD, PhD
    Sook-Bin Woo MS, DMD, MMSc
    Jamie Woodcock MD
    Stephen J. Xenias MD
    Nathaniel Yohannes
    Lisa Zaba MD
    Vijay Zawar MD
    Bonnnie Zhang MD
    Carolyn Ziemer MD
    Jeffrey P. Zwerner MD, PhD


  • Am. Journal of Trop. Med & Hygiene
  • Armed Forces Pest Management Board
  • Blackwell Publishing
  • Bugwood Network
  • Centers For Disease Control and Prevention
  • Centro Internacional de Entrenamiento e Investigaciones Mèdicas (CIDEIM)
  • Dermatology Online Journal
  • East Carolina University (ECU), Division of Dermatology
  • International Atomic Energy Agency
  • Massachusetts Medical Society
  • Oxford University Press
  • Radiological Society of North America
  • Washington Hospital Center
  • Wikipedia
  • World Health Organization
ContentsSynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyDrug Reaction DataReferences
Potentially life-threatening emergency
Neuroleptic malignant syndrome
Other Resources UpToDate PubMed
Potentially life-threatening emergency

Neuroleptic malignant syndrome

Print Images (1)
Contributors: Amber Bard, Richard L. Barbano MD, PhD
Other Resources UpToDate PubMed


Neuroleptic malignant syndrome (NMS) is a life-threatening disorder caused by exposure to dopamine antagonists (most commonly neuroleptics) or rapid withdrawal of dopamine agonists. It is characterized by hyperthermia, muscle rigidity, altered mental status, and autonomic instability. It is often accompanied by diaphoresis and tachypnea. NMS usually occurs after initiation or increase in neuroleptics within the last 72 hours, but the range can be quite long, requiring suspicion of possible NMS for several months.

Both first-generation ("typical") (FGA) and second-generation ("atypical") antipsychotics (SGA) have been shown to cause NMS in genetically susceptible individuals. Less commonly, NMS has been reported to occur with the sudden withdrawal of dopaminergic drugs, such as those used to treat Parkinson disease; mood stabilizers (eg, carbamazepine, lithium); antidepressants (eg, paroxetine, sertraline, amitriptyline); and anti-emetics (eg, metoclopramide).

There are two main hypotheses regarding the pathophysiology of NMS. The first is related to the blockade of D2 receptors in the central nervous system (CNS). Dopamine is a key neurotransmitter in both the hypothalamic thermoregulatory system and in basal ganglionic regulation of motor coordination and tone. It is thought that dopamine blockade by antipsychotics in these two systems leads to the classic signs and symptoms of NMS, including hyperthermia and muscle rigidity. The second hypothesis theorizes that the drug itself is toxic to muscle fibers in susceptible patients, resulting in calcium dysregulation and subsequent muscle damage, hyperthermia, and increased serum creatine kinase (CK).

Men aged mid-40s or younger are at greatest risk, and men are affected twice as often as women, though this may reflect an increased use of antipsychotic drugs in the male population. Risk factors include higher neuroleptic doses, recent increase in dose, switching agents, and parenteral administration. Genetic factors likely also play a role. Risk is greatest at the time of drug initiation, with rapid dose increase, with use of high-potency antipsychotics, and with use of long-acting depot forms of the medications. Polypharmacy and parenteral administration (intravascular or intramuscular) of antipsychotics also seems to increase the risk of NMS.

The core features of NMS – hyperthermia, muscular rigidity, dysautonomia, and altered mental status (AMS) – are found in the vast majority of cases, with changes in mental status most often the first to appear. Not all symptoms are present initially; thus a high index of suspicion for patients on antipsychotics should be maintained. Associated laboratory abnormalities are listed below. Atypical presentations are more likely to occur with use of the SGA clozapine, aripiprazole, or paliperidone. Patients are more frequently noted to be diaphoretic and less often rigid and tremulous.

NMS can present insidiously making its diagnosis difficult to recognize immediately. In one analysis, 70% of NMS cases began with changes in mental status ranging from mild anxiety or agitation to delirium. AMS was then followed by muscle changes, including hypertonia, tremors, and cramps. Hyperthermia then occurred, although the hallmark high fever can be delayed for more than 24 hours after the initial onset of NMS. Dysautonomia occurred next, a term encompassing diaphoresis, nausea, vomiting, fluctuations in blood pressure, cardiac arrhythmias, and other signs and symptoms.

Once AMS, rigidity, fever, and dysautonomia occur, the patient will show hematologic and biochemical changes characteristic of the syndrome within 2-3 days (most notably, leukocytosis and elevated serum CK). At this point, this patient is in danger of decompensating rapidly, and should be moved to the intensive care unit (ICU) in the event that intubation secondary to sialorrhea or chest wall muscle rigidity is necessary.

Sequelae of the syndrome include hypertensive crises, Takotsubo cardiomyopathy, acute renal failure secondary to myoglobinuria, anoxic encephalopathy, and ultimately metabolic acidosis leading to coma. Early diagnosis and adequate intervention in an ICU can lead to resolution of NMS within 3-14 days; despite this, about 12% of cases will end in death despite proper management.


G21.0 – Malignant neuroleptic syndrome

15244003 – Neuroleptic malignant syndrome

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

  • Malignant catatonia (lethal catatonia) – Lack of a drug precipitant; often has prodromal behavioral symptoms of several weeks.
  • Serotonin syndrome – Must be on serotonergic agent; more likely to present with gastrointestinal symptoms, shivering, hyperreflexia, myoclonus, and ataxia. Creatine phosphokinase (CPK) and WBC labs will be normal.
  • Anticholinergic poisoning / syndrome – Temperature not as high as in NMS; no diaphoresis, rigidity, extrapyramidal symptoms, rhabdomyolysis, or elevated CPK, but may have anticholinergic symptoms (dry skin, mydriasis, dry mouth, urinary retention) that mimic NMS.
  • Sympathomimetic poisoning
  • Malignant hyperthermia (malignant hyperpyrexia) – Exposure to halogenate anesthetic.
  • Tetanus
  • Delirium unrelated to NMS
  • Encephalitis
  • Lithium intoxication – Patient will be afebrile; CPK level will be normal.
  • Heat shock or heat stroke – No diaphoresis or rigidity.
  • Hypertensive crisis
  • Myxedema crisis – Patient will have hypothyroidism.
  • Thyrotoxicosis – Patient will have hyperthyroidism.
  • Skin burns
  • Status epilepticus
  • Toxic encephalopathy
  • Clozapine-induced hyperpyrexia – Fever is a common side effect in the early weeks of clozapine administration.
  • Acute hydrocephalus
  • Acute spinal cord injuries
  • Drug intoxication (phencyclidine, ecstasy, cocaine, amphetamine, lithium salts)
  • Porphyria
  • Adrenocorticotropic hormone (ACTH) deficiency
  • Alcohol withdrawal
  • Pheochromocytoma
  • Sepsis
  • Stroke
  • Dystonic storm

Best Tests

Subscription Required

Management Pearls

Subscription Required


Subscription Required

Drug Reaction Data

Below is a list of drugs with literature evidence indicating an adverse association with this diagnosis. The list is continually updated through ongoing research and new medication approvals. Click on Citations to sort by number of citations or click on Medication to sort the medications alphabetically.

Subscription Required


Subscription Required

Last Updated: 11/21/2017
Copyright © 2018 VisualDx®. All rights reserved.
Potentially life-threatening emergency
Neuroleptic malignant syndrome
Print 1 Images
Neuroleptic malignant syndrome : Agitation, Delirium, Rigidity, Diaphoresis, CPK elevated, High fever, HR increased, RR increased, Hyperthermia
Copyright © 2018 VisualDx®. All rights reserved.